Trials / Completed
CompletedNCT01684852
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (BAT04) Compared to HA Eye Drops in the Treatment of Dry Eye Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (actual)
- Sponsor
- Bitop AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical device, drug-like |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-09-13
- Last updated
- 2026-01-29
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01684852. Inclusion in this directory is not an endorsement.